Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-01 Sale | 2021-12-03 5:01 pm | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $3.96 | $108,900 | 19,502 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 5:34 pm | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $5 | $137,500 | 47,002 (Direct) | View |
| 2021-10-01 Sale | 2021-10-05 5:01 pm | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $4.89 | $134,475 | 42,412 (Direct) | View |
| 2021-09-20 Sale | 2021-09-22 5:01 pm | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 32,960 | $4.9717 | $163,866 | 69,912 (Direct) | View |
| 2019-10-07 Purchase | 2019-10-07 7:21 pm | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan VP of Business Dev't | 500 | $15 | $7,500 | 64,822 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-28 Option Award | 2022-08-01 5:04 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer | 60,000 | $0 | 81,462 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer | 8,390 | $0.805 | 21,462 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 5:03 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 1,989 | $1.82 | 102,452 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:03 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 88,600 | $0 | 102,452 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 5:02 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 1,326 | $1.74 | 15,841 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0.92 | 19,502 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:01 pm | N/A 2027-02-16 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0 | 19,502 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 5:34 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0.92 | 47,002 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 5:34 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0 | 47,002 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0.92 | 42,412 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 5:01 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0 | 42,412 (Direct) | View |
| 2021-09-20 Exercise | 2021-09-22 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0.92 | 69,912 (Direct) | View |
| 2021-09-20 Exercise | 2021-09-22 5:01 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 27,500 | $0 | 69,912 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan Chief Business Officer | 1,724 | $4.59 | 22,627 (Direct) | View |
| 2021-08-25 Tax Withholding | 2021-08-27 5:02 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan Chief Business Officer | 1,149 | $3.98 | 24,351 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-11 5:30 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan Chief Business Officer | 15,000 | $0 | 25,500 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 7:01 pm | N/A 2031-02-25 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan VP of Business Dev't | 51,100 | $0 | 51,600 (Direct) | View |
| 2020-03-24 Option Award | 2020-03-26 5:01 pm | N/A 2030-03-24 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan VP of Business Dev't | 12,800 | $0 | 12,800 (Direct) | View |
| 2019-10-07 Option Award | 2019-10-07 7:21 pm | N/A 2029-10-02 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan VP of Business Dev't | 64,322 | $0 | 64,822 (Direct) | View |
Ownership | 2019-10-02 6:04 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan VP of Business Dev't | 0 | $0 | 219,033 (Direct) | View |